The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation-Reference-Cited by-同舟云学术

The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation

Published:2019-12-03 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Heinze Annekathrin,Grebe Beatrice,Bremm Melanie,Huenecke Sabine,Munir Tasleem Ah.,Graafen Lea,Frueh Jochen T.,Merker Michael,Rettinger Eva,Soerensen Jan,Klingebiel Thomas,Bader Peter,Ullrich Evelyn,Cappel Claudia

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference78 articles.

1. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report;Cohn;J Clin Oncol,2009

2. Neuroblastoma;Colon;Adv Pediatr,2011

3. Recent advances in neuroblastoma;Maris;N Engl J Med,2010

4. Anti-GD2 immunotherapy for neuroblastoma;Sait;Expert Rev Anticancer Ther,2017

5. Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy;Morgenstern;J Pediatr Hematol Oncol,2013

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD;Cancer Cell;2024-08

3. A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy;Cancer Immunology, Immunotherapy;2024-07-03

4. The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches;Cancers;2024-05-13

5. Immunotherapy Options for Neuroblastoma: What is on the Horizon?;Current Molecular Biology Reports;2024-05-13